HOLLIS EDEN PHARMACEUTICALS INC /DE/
HOLLIS EDEN PHARMACEUTICALS INC /DE/ (HEPH) is a publicly traded company in the Unknown sector. Across all available filings, 9 corporate insiders have executed 59 transactions totaling $349.1K, demonstrating a bearish sentiment with -$181.0K in net insider flow. The most recent transaction on Mar 5, 2007 involved a sale of 300 shares valued at $1.6K.
HEPH Insider Activity Summary
Who Is Buying HEPH Stock?
No significant insider buying has been recorded for HEPH in the recent period.
Who Is Selling HEPH Stock?
No significant insider selling has been recorded for HEPH in the recent period.
Is HOLLIS EDEN PHARMACEUTICALS INC /DE/ Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for HEPH is bearish with an Insider Alignment Score of 24/100 and a net flow of -$181.0K. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
HEPH Frequently Asked Questions
Understanding HEPH Insider Activity
Insider trading at HOLLIS EDEN PHARMACEUTICALS INC /DE/ (HEPH) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 9 insiders are actively trading HEPH stock, having executed 59 transactions in the past 90 days. The most active insider is Robert W. Weber (Executive), who has made 27 transactions totaling $230.1K.
Related Tools
Track HOLLIS EDEN PHARMACEUTICALS INC /DE/ Insider Activity
Get notified when executives and directors at HEPH file new Form 4 transactions